Eli Lilly has had a presence in Kinsale since 1978, a relationship that has seen both places prosper and grow across the ...

Eli Lilly (NYSE:LLY) is expanding its manufacturing footprint in Ireland with a $1.8B investment. The drugmaker will undertake a $1B expansion of its Limerick manufacturing site to boost ...

Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely popular obesity drug and a newly approved treatment for Alzheimer's, the drugmaker ...

Eli Lilly said it will spend $1.8 billion to boost production in Ireland of its popular diabetes and weight-loss drugs, along with ingredients for its recently approved Alzheimer’s treatment ...

Indianapolis-based Eli Lilly and Co. on Thursday announced plans to spend $1.8 billion on two of its manufacturing sites in Ireland to boost production of medicines for Alzheimer’s disease ...

CEO cites quality of Emerald Isle’s workforce and government support. Eli Lilly & Co. will make its Dunderrow campus in Kinsale, Ireland, the pharma giant’s main launch site for all new ...

The U.S. trade deficit with Ireland has surged as $36 billion in hormone shipments for weight-loss and diabetes drugs were ...

Eli Lilly and Co. plans to invest about $440 million in a new pharmaceutical plant at an existing company site in County Cork in southern Ireland. The facility in Kinsale will require as many as ...

The site, one of 6 Lilly bulk manufacturing locations worldwide, is the production home for potential blockbuster Alzheimer treatment solanezumab, InPharm reports. Eli Lilly isn't the only big ...

INDIANAPOLIS — Indianapolis-based Eli Lilly and Company announced nearly $2 billion in manufacturing investments in Ireland on Thursday. The pharmaceutical company said $1 billion of that investment ...

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.